The effect of incorporating clinical pharmacist-led intervention in the management of type 2 Diabetes
TL;DR
Incorporating pharmacist-led interventions into T2DM management is crucial for improving patient adherence and life expectancy and healthcare systems should prioritize multidisciplinary collaboration for chronic disease management, particularly in resource-limited settings.
Abstract
The rising prevalence of type 2 diabetes mellitus (T2DM) has increased complications, particularly in low-income countries. Non-adherence to medication significantly contributes to vascular issues, but pharmacist-led interventions can improve health outcomes and quality of life. Objectives: This study investigated the impact of clinical pharmacist-led interventions on medication adherence and quality of life among T2DM patients. Methods: A retrospective cohort study was conducted at a hospital endocrine clinic. Participants (n=106) were divided into cohorts with and without a history of pharmacist intervention. Quality of life and adherence were assessed using the SF-36 questionnaire and MMAS-8 scale, respectively. Data analysis employed paired t-tests via SPSS version 22, with significance set at p < 0.005. Results: Of the 106 participants, 55 (52%) had received pharmacist interventions. Statistically significant differences (p < 0.001) were observed between groups. The intervention cohort demonstrated significantly higher medication adherence and superior quality of life compared to the non-intervention group. Conclusion: Incorporating pharmacist-led interventions into T2DM management is crucial for improving patient adherence and life expectancy. Healthcare systems should prioritize multidisciplinary collaboration for chronic disease management, particularly in resource-limited settings, to optimize therapeutic outcomes.